Cargando…

Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk: Meta-analysis of 10,549 cases and 19,316 controls

Studies investigating the association between interleukin-6 (IL-6) gene-174 G/C polymorphism (rs1800795) and thrombosis disorder risk reported conflicting results. The aim of our study was to assess the association between the IL-6 gene 174 G/C polymorphisms and the risk of thrombosis disorders. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Honggang, Zhang, Yue, Yao, Yonghua, Guo, Tao, Wang, Huafang, Mei, Heng, Hu, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058815/
https://www.ncbi.nlm.nih.gov/pubmed/27399086
http://dx.doi.org/10.1097/MD.0000000000004030
_version_ 1782459310990688256
author Ren, Honggang
Zhang, Yue
Yao, Yonghua
Guo, Tao
Wang, Huafang
Mei, Heng
Hu, Yu
author_facet Ren, Honggang
Zhang, Yue
Yao, Yonghua
Guo, Tao
Wang, Huafang
Mei, Heng
Hu, Yu
author_sort Ren, Honggang
collection PubMed
description Studies investigating the association between interleukin-6 (IL-6) gene-174 G/C polymorphism (rs1800795) and thrombosis disorder risk reported conflicting results. The aim of our study was to assess the association between the IL-6 gene 174 G/C polymorphisms and the risk of thrombosis disorders. Thirty four case–control studies in 29 articles with 29,865 individuals were incorporated in this meta-analysis by searching the public databases including Medline, Embase, and ISI Web of Science databases as of June 1st, 2015. The odds ratio (OR) and 95% confidence interval (95%CI) were used to assess the strength of the association. By pooling all studies, there was marginal association between and the risk of thrombotic disorders (1.09[0.97–1.22]), arterial thrombotic disorders (1.08[0.95–1.23]), and myocardial infarction (MI, 1.14[0.99–1.32]) under dominant genetic effect (C carriers vs GG). In subgroup analyses stratified by ethnicity, study scale, thrombotic category, and country, the results indicated that IL-6 gene-174 G/C polymorphism was significantly associated with increased risk of thrombotic disorders given the conditional such as Asians, large sample-sized, MI, population-based, and Indian studies (C carriers vs GG: 1.39 [1.13–1.72] and C allele vs G allele: 1.36 [1.18–1.56] for Asian; C carriers vs GG: 1.15 [1.01–1.31] and C allele vs G allele: 1.12 [1.01–1.23] for large sample-sized studies; C allele vs G allele: 1.10 [1.03–1.18] for population-based studies; and C carriers vs GG: 1.40 [1.19–1.65] for Indian studies). We did not observe significant association between IL-6-174 G/C and the risk of Caucasians, small sample-sized studies, stroke and venous studies, and other country studies. This meta-analysis suggests that IL-6 gene-174 G/C polymorphism may be marginally associated with risk of thrombotic disorders, arterial disorders, MI especially for Asian, Indian, population-based, and large sample-sized studies. More studies with larger sample size and well-designed studies might be warranted.
format Online
Article
Text
id pubmed-5058815
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-50588152016-11-18 Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk: Meta-analysis of 10,549 cases and 19,316 controls Ren, Honggang Zhang, Yue Yao, Yonghua Guo, Tao Wang, Huafang Mei, Heng Hu, Yu Medicine (Baltimore) 4800 Studies investigating the association between interleukin-6 (IL-6) gene-174 G/C polymorphism (rs1800795) and thrombosis disorder risk reported conflicting results. The aim of our study was to assess the association between the IL-6 gene 174 G/C polymorphisms and the risk of thrombosis disorders. Thirty four case–control studies in 29 articles with 29,865 individuals were incorporated in this meta-analysis by searching the public databases including Medline, Embase, and ISI Web of Science databases as of June 1st, 2015. The odds ratio (OR) and 95% confidence interval (95%CI) were used to assess the strength of the association. By pooling all studies, there was marginal association between and the risk of thrombotic disorders (1.09[0.97–1.22]), arterial thrombotic disorders (1.08[0.95–1.23]), and myocardial infarction (MI, 1.14[0.99–1.32]) under dominant genetic effect (C carriers vs GG). In subgroup analyses stratified by ethnicity, study scale, thrombotic category, and country, the results indicated that IL-6 gene-174 G/C polymorphism was significantly associated with increased risk of thrombotic disorders given the conditional such as Asians, large sample-sized, MI, population-based, and Indian studies (C carriers vs GG: 1.39 [1.13–1.72] and C allele vs G allele: 1.36 [1.18–1.56] for Asian; C carriers vs GG: 1.15 [1.01–1.31] and C allele vs G allele: 1.12 [1.01–1.23] for large sample-sized studies; C allele vs G allele: 1.10 [1.03–1.18] for population-based studies; and C carriers vs GG: 1.40 [1.19–1.65] for Indian studies). We did not observe significant association between IL-6-174 G/C and the risk of Caucasians, small sample-sized studies, stroke and venous studies, and other country studies. This meta-analysis suggests that IL-6 gene-174 G/C polymorphism may be marginally associated with risk of thrombotic disorders, arterial disorders, MI especially for Asian, Indian, population-based, and large sample-sized studies. More studies with larger sample size and well-designed studies might be warranted. Wolters Kluwer Health 2016-07-08 /pmc/articles/PMC5058815/ /pubmed/27399086 http://dx.doi.org/10.1097/MD.0000000000004030 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 4800
Ren, Honggang
Zhang, Yue
Yao, Yonghua
Guo, Tao
Wang, Huafang
Mei, Heng
Hu, Yu
Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk: Meta-analysis of 10,549 cases and 19,316 controls
title Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk: Meta-analysis of 10,549 cases and 19,316 controls
title_full Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk: Meta-analysis of 10,549 cases and 19,316 controls
title_fullStr Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk: Meta-analysis of 10,549 cases and 19,316 controls
title_full_unstemmed Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk: Meta-analysis of 10,549 cases and 19,316 controls
title_short Association between the interleukin-6 genetic polymorphism 174 G/C and thrombosis disorder risk: Meta-analysis of 10,549 cases and 19,316 controls
title_sort association between the interleukin-6 genetic polymorphism 174 g/c and thrombosis disorder risk: meta-analysis of 10,549 cases and 19,316 controls
topic 4800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058815/
https://www.ncbi.nlm.nih.gov/pubmed/27399086
http://dx.doi.org/10.1097/MD.0000000000004030
work_keys_str_mv AT renhonggang associationbetweentheinterleukin6geneticpolymorphism174gcandthrombosisdisorderriskmetaanalysisof10549casesand19316controls
AT zhangyue associationbetweentheinterleukin6geneticpolymorphism174gcandthrombosisdisorderriskmetaanalysisof10549casesand19316controls
AT yaoyonghua associationbetweentheinterleukin6geneticpolymorphism174gcandthrombosisdisorderriskmetaanalysisof10549casesand19316controls
AT guotao associationbetweentheinterleukin6geneticpolymorphism174gcandthrombosisdisorderriskmetaanalysisof10549casesand19316controls
AT wanghuafang associationbetweentheinterleukin6geneticpolymorphism174gcandthrombosisdisorderriskmetaanalysisof10549casesand19316controls
AT meiheng associationbetweentheinterleukin6geneticpolymorphism174gcandthrombosisdisorderriskmetaanalysisof10549casesand19316controls
AT huyu associationbetweentheinterleukin6geneticpolymorphism174gcandthrombosisdisorderriskmetaanalysisof10549casesand19316controls